Additionally, diabetes-related emotional distress and depression symptom severity have been identified as risk factors for medication non-adherence in T2DM [136, 137]
Ongoing Research Current research is focused on exploring the potential benefits of semaglutide in various areas, including: Non-alcoholic steatohepatitis (NASH): Semaglutide is being investigated as a potential treatment for NASH
Research shows that adding medical support for weight loss to a comprehensive weight loss program, including a healthy diet and exercise, can help obese and overweight adults lose significantly more weight than losing weight without medical support
They are endogenously sourced from PPG neurons that are situated caudally in the solitary tract of the brainstem [47, 48]
Internal resistance is not a major concern because the current draw is tiny
As we delve further into semaglutides role in the management of diabetes and obesity, the balance between its benefits and risks remains a focal point of discussion among healthcare providers and researchers alike